Filtros de búsqueda

Lista de obras de

(211)Astatine-Conjugated Monoclonal CD45 Antibody-Based Nonmyeloablative Conditioning for Stem Cell Gene Therapy

artículo científico publicado en 2015

90Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma

artículo científico publicado en 2020

A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients

artículo científico publicado en 2009

A limited sampling schedule to estimate mycophenolic Acid area under the concentration-time curve in hematopoietic cell transplantation recipients

artículo científico publicado en 2011

A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2011

A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients

scientific article published on 02 August 2013

A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation

artículo científico publicado en 2014

Acute renal failure after nonmyeloablative hematopoietic cell transplantation

artículo científico publicado en 2004

Addition of sirolimus to standard cyclosporine plus mycophenolate mofetil-based graft-versus-host disease prophylaxis for patients after unrelated non-myeloablative haemopoietic stem cell transplantation: a multicentre, randomised, phase 3 trial

artículo científico publicado en 2019

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

artículo científico publicado en 2003

Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders

artículo científico publicado en 2017

Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities ⬇️

artículo científico publicado el 6 de octubre de 2010

Allogeneic Hematopoietic Cell Transplantation for Patients with Mixed Phenotype Acute Leukemia

artículo científico publicado en 2016

Allogeneic Hematopoietic Cell Transplantation in the Outpatient Setting

artículo científico publicado en 2019

Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas

artículo científico publicado en 2010

Allogeneic haematopoietic cell transplantation for myelofibrosis in 30 patients 60–78 years of age ⬇️

artículo científico publicado el 17 de febrero de 2011

Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experience.

artículo científico publicado en 2016

Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome

artículo científico publicado en 2009

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

artículo científico publicado en 2004

Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia (AML) patients 60-75 years in first complete remission (CR1): an alliance (A151509), SWOG, ECOG-ACRIN, and CIBMTR study

artículo científico publicado en 2019

Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: predicting acute graft-versus-host disease and graft-versus-tumor effects

artículo científico publicado en 2013

Allogeneic hematopoietic cell transplantation for indolent non-Hodgkin lymphoma: indications and outcomes

artículo científico publicado en 2013

Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens

artículo científico publicado en 2004

Allogeneic hematopoietic cell transplantation for renal cell carcinoma: ten years after ⬇️

artículo científico publicado el 21 de marzo de 2011

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades

artículo científico publicado en 2020

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

scientific article published on 14 August 2003

Allogeneic transplantation for advanced acute myeloid leukemia: The value of complete remission

artículo científico publicado en 2017

Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant ⬇️

artículo científico publicado el 1 de abril de 2003

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

artículo científico publicado en 2003

Anti-tumor activity of an ICAM-3 antibody (ICM3) Against human leukemic xenograft tumors in nude mice

Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2011

Association of Distance from Transplantation Center and Place of Residence on Outcomes after Allogeneic Hematopoietic Cell Transplantation

artículo científico publicado en 2016

Association of fludarabine pharmacokinetic/dynamic biomarkers with donor chimerism in nonmyeloablative HCT recipients

artículo científico publicado en 2015

Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model.

artículo científico publicado en 2015

Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211

artículo científico publicado en 2009

Biokinetics of Radiolabeled Monoclonal Antibody BC8: Differences in Biodistribution and Dosimetry among Hematologic Malignancies

artículo científico publicado en 2020

Bismuth 213-labeled anti-CD45 radioimmunoconjugate to condition dogs for nonmyeloablative allogeneic marrow grafts

artículo científico publicado en 2002

Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach

artículo científico publicado en 2020

C19orf48 encodes a minor histocompatibility antigen recognized by CD8+ cytotoxic T cells from renal cell carcinoma patients

artículo científico publicado en 2008

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

artículo científico publicado en 2013

Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

artículo científico publicado en 2014

Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.

artículo científico publicado en 2007

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation

artículo científico publicado en 2014

Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors

artículo científico publicado en 2007

Comparative analysis of total body irradiation (TBI)-based and non-TBI-based myeloablative conditioning for acute myeloid leukemia in remission with or without measurable residual disease

scientific article published on 03 December 2019

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

artículo científico publicado en 2004

Comparing outcomes of matched related donor and matched unrelated donor hematopoietic cell transplants in adults with B-Cell acute lymphoblastic leukemia.

artículo científico publicado en 2017

Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation

artículo científico publicado en 2005

Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients

artículo científico publicado en 2019

Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation

artículo científico publicado en 2005

Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma

artículo científico publicado en 2008

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

artículo científico publicado en 2020

Conditioning regimens for hematopoietic cell transplantation: one size does not fit all

artículo científico publicado en 2014

Conditioning with α-emitter based radioimmunotherapy in canine allogeneic hematopoietic cell transplantation

artículo científico publicado en 2012

Cord-Blood Transplantation in Patients with Minimal Residual Disease

artículo científico publicado en 2016

Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimens

artículo científico publicado en 2014

Costs of second allogeneic hematopoietic cell transplantation

artículo científico publicado en 2013

Current status of hematopoietic stem cell transplantation after nonmyeloablative conditioning

artículo científico publicado en 2005

Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis

artículo científico publicado en 2017

Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study

artículo científico publicado en 2016

Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs

artículo científico publicado en 2011

Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation

artículo científico publicado en 2011

Defining the intensity of conditioning regimens: working definitions

artículo científico publicado en 2009

Delaying DLA-haploidentical hematopoietic cell transplantation after total body irradiation

artículo científico publicado en 2009

Description and prognostic significance of the kinetics of minimal residual disease status in adults with acute lymphoblastic leukemia treated with HyperCVAD.

artículo científico publicado en 2018

Design and Validation of an Augmented Hematopoietic Cell Transplantation-Comorbidity Index Comprising Pretransplant Ferritin, Albumin, and Platelet Count for Prediction of Outcomes after Allogeneic Transplantation

artículo científico publicado en 2015

Disability related to chronic graft --host disease after alternative donor hematopoietic cell transplantation

scholarly article by Giancarlo Fatobene et al published April 2019 in Haematologica

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

artículo científico publicado en 2016

Dog leukocyte antigen nonidentical unrelated canine marrow grafts: enhancement of engraftment by CD4 and CD8 T cells.

artículo científico publicado en 2003

Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.

artículo científico publicado en 2006

Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and reduced-intensity conditioning in a preclinical canine model

artículo científico publicado en 2003

Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose

artículo científico publicado en 2013

Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation

artículo científico publicado en 2009

Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation

artículo científico publicado en 2011

Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation model

artículo científico publicado en 2005

EASIX and mortality after allogeneic stem cell transplantation

artículo científico publicado en 2019

EASIX in patients with acute graft-versus-host disease: a retrospective cohort analysis

artículo científico publicado en 2017

Effect of allogeneic hematopoietic cell transplantation in first complete remission on post-relapse complete remission rate and survival in acute myeloid leukemia

artículo científico publicado en 2015

Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation

artículo científico publicado en 2009

Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation

artículo científico publicado en 2012

Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation

artículo científico publicado en 2002

Evaluation of allogeneic transplantation in first or later minimal residual disease - negative remission following adult-inspired therapy for acute lymphoblastic leukemia

artículo científico publicado en 2016

Evaluation of posttransplant methotrexate to facilitate engraftment in the canine major histocompatibility complex-haploidentical nonmyeloablative transplant model

artículo científico publicado en 2010

Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning

artículo científico publicado en 2007

Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation

scientific article published on 01 March 2006

Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation

scientific article published on 08 August 2006

Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation

artículo científico publicado en 2006

Failure-free survival after initial systemic treatment of chronic graft-versus-host disease

artículo científico publicado en 2014

Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease

artículo científico publicado en 2013

Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, M

artículo científico publicado en 2005

Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.

artículo científico publicado en 2012

Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

artículo científico publicado en 2008

Fludarabine and 2-Gy TBI is superior to 2 Gy TBI as conditioning for HLA-matched related hematopoietic cell transplantation: a phase III randomized trial

artículo científico publicado en 2013

Frequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission

artículo científico publicado en 2013

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

artículo científico publicado en 2003

Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2013

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

artículo científico publicado en 2005

HLA-Haploidentical Hematopoietic Cell Transplantation for Treatment of Non-Malignant Diseases Using Nonmyeloablative Conditioning and Post-Transplant Cyclophosphamide

artículo científico publicado en 2020

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

artículo científico publicado en 2008

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia

artículo científico publicado en 2005

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

artículo científico publicado en 2003

Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes.

artículo científico publicado en 2017

Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents.

artículo científico publicado en 2017

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

artículo científico publicado en 2005

Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia

artículo científico publicado en 2005

Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia

artículo científico publicado en 2007

Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematol

artículo científico publicado en 2007

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

artículo científico publicado en 2007

Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

artículo científico publicado en 2008

Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality

artículo científico publicado en 2002

Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients

artículo científico publicado en 2003

High prevalence of potential drug interactions affecting mycophenolic acid pharmacokinetics in nonmyeloablative hematopoietic stem cell transplant recipients

artículo científico publicado en 2013

Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation

artículo científico publicado en 2011

Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning ⬇️

artículo científico publicado el 1 de octubre de 2003

Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation

artículo científico publicado en 2011

Impact of Rituximab and Host/Donor Fc Receptor Polymorphisms after Allogeneic Hematopoietic Cell Transplantation for CD20+ B-cell Malignancies

artículo científico publicado en 2020

Impact of acute kidney injury on long-term mortality after nonmyeloablative hematopoietic cell transplantation

artículo científico publicado en 2008

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blo

artículo científico publicado en 2019

Impact of donor age on outcome after allogeneic hematopoietic cell transplantation

artículo científico publicado en 2014

Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML

scientific article published on 23 January 2020

Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation ⬇️

artículo científico publicado el 26 de mayo de 2010

Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation

artículo científico publicado en 2003

Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy

artículo científico publicado en 2006

In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs

scientific article published on 23 July 2015

In response to "American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults"

artículo científico publicado en 2020

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

artículo científico publicado en 2002

Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study

artículo científico publicado en 2002

Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

artículo científico publicado en 2013

Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients

artículo científico publicado en 2018

Intracellular disposition of fludarabine triphosphate in human natural killer cells

artículo científico publicado en 2008

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia

artículo científico publicado en 2017

Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center

article by Takahiro Fukuda et al published July 2004 in Biology of Blood and Marrow Transplantation

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

artículo científico publicado en 2004

Long-Term Follow-Up of 90Y-Ibritumomab Tiuxetan, Fludarabine, and Total Body Irradiation-Based Nonmyeloablative Allogeneic Transplant Conditioning for Persistent High-Risk B Cell Lymphoma

scientific article published on 03 July 2018

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma

scholarly article by Enrico Maffini et al published February 2019 in Haematologica

Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting

artículo científico publicado en 2008

Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies

artículo científico publicado en 2011

Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation

artículo científico publicado en 2014

Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

artículo científico publicado en 2015

Low-Dose Azacitidine with DNMT1 Level Monitoring to Treat Post-Transplantation Acute Myelogenous Leukemia or Myelodysplastic Syndrome Relapse

scientific article published on 30 December 2018

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

artículo científico publicado en 2002

Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial

artículo científico publicado en 2009

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

artículo científico publicado en 2016

Minimal Identifiable Disease and the Role of Conditioning Intensity in Hematopoietic Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Evolving from Myelodysplastic Syndrome

artículo científico publicado en 2016

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

artículo científico publicado en 2004

Multi-centre validation of the prognostic value of the haematopoietic cell transplantation- specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation

artículo científico publicado en 2015

Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate, but not High Disease Risk Index: A CIBMTR Study: Superior DFS with MA

scientific article published on 30 September 2020

Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience

artículo científico publicado en 2008

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

artículo científico publicado en 2003

Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia

artículo científico publicado en 2011

Non-myeloablative transplantation.

artículo científico publicado en 2002

Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation

artículo científico publicado en 2011

Nonmyeloablative allogeneic hematopoietic cell transplantation

artículo científico publicado en 2016

Nonmyeloablative allogeneic hematopoietic cell transplantation for relapsed or refractory Waldenstrom macroglobulinemia: Evidence for a graft-versus-lymphoma effect.

artículo científico publicado en 2018

Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia

artículo científico publicado en 2010

Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma

artículo científico publicado en 2007

Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives

artículo científico publicado en 2002

Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma

artículo científico publicado en 2007

Nonrelapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation

artículo científico publicado en 2013

Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission

artículo científico publicado en 2014

Optimizing reduced-intensity conditioning regimens for myeloproliferative neoplasms

artículo científico publicado en 2010

Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.

artículo científico publicado en 2010

Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation

artículo científico publicado en 2011

Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia

artículo científico publicado en 2007

Outcomes among patients with recurrent high-risk hematologic malignancies after allogeneic hematopoietic cell transplantation.

artículo científico publicado en 2007

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

scientific article published on 01 June 2019

Outcomes of hematopoietic cell transplantation using donors or recipients with inherited chromosomally integrated HHV-6.

artículo científico publicado en 2017

Outcomes with myeloid malignancies

artículo científico publicado en 2006

Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation

artículo científico publicado en 2005

Pharmacokinetic and pharmacodynamic analysis of inosine monophosphate dehydrogenase activity in hematopoietic cell transplantation recipients treated with mycophenolate mofetil

artículo científico publicado en 2014

Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk Lymphoma

artículo científico publicado en 2019

Phase I/II multisite trial of optimally dosed clofarabine and low-dose TBI for hematopoietic cell transplantation in acute myeloid leukemia

scientific article published on 08 November 2019

Pilot study of a (213)bismuth-labeled anti-CD45 mAb as a novel nonmyeloablative conditioning for DLA-haploidentical littermate hematopoietic transplantation

artículo científico publicado en 2010

Plerixafor-moblized stem cells alone are capable of inducing early engraftment across the MHC-haploidentical canine barrier

artículo científico publicado en 2010

Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration

artículo científico publicado en 2014

Pre-Transplant Consolidation is Not Beneficial for Adults with ALL Undergoing Myeloablative Allogeneic Transplantation

artículo científico publicado en 2017

Pre-Transplant Ferritin, Albumin and Platelet Count Add Prognostic Information to Comorbidities for Allogeneic Hematopoietic Cell Transplantation (HCT) Outcomes: A Multi-Center Discovery-Validation Study

artículo científico publicado en 2014

Pre-transplant bone marrow monocytic myeloid-derived suppressor cell frequency is not associated with outcome after allogeneic hematopoietic cell transplantation for acute myeloid leukemia in remission

scientific article published on 25 February 2019

Pre-transplant comorbidity burden and post-transplant chronic graft-versus-host disease

artículo científico publicado en 2015

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality.

artículo científico publicado en 2014

Prognostic Performance of the Augmented Hematopoietic Cell Transplantation-Specific Comorbidity/Age Index in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation from Alternative Graft Sources

scientific article published on 28 November 2018

Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation

artículo científico publicado en 2011

Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation

artículo científico publicado en 2005

Prolonged allogeneic marrow engraftment following nonmyeloablative conditioning using 100 cGy total body irradiation and pentostatin before and pharmacological immunosuppression after transplantation

artículo científico publicado en 2005

Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation

artículo científico publicado en 2006

Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study

artículo científico publicado en 2004

Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome

artículo científico publicado en 2014

Reagents for astatination of biomolecules. 4. Comparison of maleimido-closo-decaborate(2-) and meta-[(211)At]astatobenzoate conjugates for labeling anti-CD45 antibodies with [(211)At]astatine

artículo científico publicado en 2009

Reagents for astatination of biomolecules. 6. An intact antibody conjugated with a maleimido-closo-decaborate(2-) reagent via sulfhydryl groups had considerably higher kidney concentrations than the same antibody conjugated with an isothiocyanato-cl

artículo científico publicado en 2012

Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation

artículo científico publicado en 2014

Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.

artículo científico publicado en 2006

Reduced intensity conditioned allograft yields favorable survival for older adults with B-cell acute lymphoblastic leukemia

artículo científico publicado en 2016

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

artículo científico publicado en 2020

Reduced intensity conditioning for allogeneic hematopoietic cell transplantation: current perspectives

artículo científico publicado en 2007

Reduced mortality after allogeneic hematopoietic-cell transplantation

artículo científico publicado en 2010

Reduced toxicity and prompt engraftment after minimal conditioning of a patient with Fanconi anemia undergoing hematopoietic stem cell transplantation from an HLA-matched unrelated donor

artículo científico publicado en 2003

Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders

artículo científico publicado en 2008

Reduced-intensity conditioning for unrelated donor progenitor cell transplantation: long-term follow-up of the first 285 reported to the national marrow donor program.

artículo científico publicado en 2007

Reduced-intensity conditioning in allogeneic stem cell transplantation for hematological malignancies: a historical perspective

artículo científico publicado en 2011

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research

artículo científico publicado en 2009

Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome ⬇️

artículo científico publicado el 1 de octubre de 2003

Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

artículo científico publicado en 2007

Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases

artículo científico publicado en 2002

Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant.

artículo científico publicado en 2017

Reversal of Low Donor Chimerism after Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion: A Prospective Phase II Multicenter Trial

artículo científico publicado en 2017

Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation

scientific article published on 10 July 2003

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning ⬇️

artículo científico publicado el 10 de abril de 2003

Rituximab-based allogeneic transplant for chronic lymphocytic leukemia with comparison to historical experience

scientific article published on 03 September 2019

Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy

artículo científico publicado en 2019

Safety of treatment with DLA-identical or unrelated mesenchymal stromal cells in DLA-identical canine bone marrow transplantation

artículo científico publicado en 2013

Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts

artículo científico publicado en 2009

Second allogeneic hematopoietic cell transplantation for relapse after first allografts

artículo científico publicado en 2019

Selective T-cell ablation with bismuth-213-labeled anti-TCRalphabeta as nonmyeloablative conditioning for allogeneic canine marrow transplantation

artículo científico publicado en 2003

Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission

artículo científico publicado en 2013

Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen mismatched donors

artículo científico publicado en 2020

Steroids Versus Steroids Plus Additional Agent in Frontline Treatment of Acute Graft-versus-Host Disease: A Systematic Review and Meta-Analysis of Randomized Trials

artículo científico publicado en 2016

Survival, Nonrelapse Mortality, and Relapse-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: Comparing 2003-2007 Versus 2013-2017 Cohorts

scientific article published on 21 January 2020

Tandem autologous/allogeneic hematopoietic cell transplantation with bortezomib maintenance therapy for high-risk myeloma

scientific article published on 09 November 2017

Targeted cancer therapy and immunosuppression using radiolabeled monoclonal antibodies

artículo científico publicado en 2004

Targeted cancer therapy using radiolabeled monoclonal antibodies

artículo científico publicado en 2005

The ASTCT-NMDP ACCESS Initiative: A Collaboration to Address and Sustain Equal Outcomes for All Across the Hematopoietic Cell Transplantation and Cellular Therapy Ecosystem

artículo científico publicado en 2022

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation

artículo científico publicado en 2012

The cumulative burden of double-stranded DNA virus detection after allogeneic HCT is associated with increased mortality

artículo científico publicado en 2017

The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation

artículo científico publicado en 2010

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia

The role of cancer vaccines following autologous stem cell rescue in breast and ovarian cancer patients: experience with the STn-KLH vaccine (Theratope)

scientific article published on 01 February 2003

The α-emitter astatine-211 targeted to CD38 can eradicate multiple myeloma in a disseminated disease model

artículo científico publicado en 2019

Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and 90Y-DOTA

artículo científico publicado en 2020

Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age

artículo científico publicado en 2010

Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation

artículo científico publicado en 2009

Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation

scientific article published on 16 April 2019

Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms

scientific article published on 10 January 2019

Transmission and expansion of HOXB4-induced leukemia in two immunosuppressed dogs: implications for a new canine leukemia model

scientific article published on 17 July 2009

Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors

artículo científico publicado en 2005

Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia

scientific article published on 16 January 2014

Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibility

artículo científico publicado en 2002

Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing

artículo científico publicado en 2006

Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.

artículo científico publicado en 2006

Urinary elafin and kidney injury in hematopoietic cell transplant recipients

artículo científico publicado en 2014

Vaccination as a treatment for breast or ovarian cancer

artículo científico publicado en 2004

Vaccination with Theratope (STn-KLH) as treatment for breast cancer

artículo científico publicado en 2004

What is the role for donor natural killer cells after nonmyeloablative conditioning?

scientific article published on May 2009

Who is fit for allogeneic transplantation?

artículo científico publicado en 2010

Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma

artículo científico publicado en 2020

Yttrium-90-labeled anti-CD45 antibody followed by a reduced-intensity hematopoietic cell transplantation for patients with relapsed/refractory leukemia or myelodysplasia

scientific article published on 03 October 2019

cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies

artículo científico publicado en 2018

α-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After 211At-Radioimmunotherapy for Hematopoietic Cell Transplantation

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda